Does osteoprotegerin or receptor activator of nuclear factor-kappaB ligand mediate the association between bone and coronary artery calcification?

about

Mechanisms linking osteoporosis with cardiovascular calcification.Coronary Artery Calcium Score and Bone Metabolism: A Pilot Study in Postmenopausal Women

P2860

Q35575965-FB59872E-10A2-4891-9A2A-AC9530A2EB1E Q37710315-0575ECBA-870F-410E-B0DF-7B226944CE4A

P2860

Does osteoprotegerin or receptor activator of nuclear factor-kappaB ligand mediate the association between bone and coronary artery calcification?

Item

http://www.wikidata.org/entity/Q36661096

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Does osteoprotegerin or recept ...... coronary artery calcification?

@ast

Does osteoprotegerin or recept ...... coronary artery calcification?

@en

type

Item

label

Does osteoprotegerin or recept ...... coronary artery calcification?

@ast

Does osteoprotegerin or recept ...... coronary artery calcification?

@en

prefLabel

Does osteoprotegerin or recept ...... coronary artery calcification?

@ast

Does osteoprotegerin or recept ...... coronary artery calcification?

@en

P1476

Does osteoprotegerin or recept ...... coronary artery calcification?

@en

P2093

Gail A Laughlin

http://www.w3.org/2001/XMLSchema#string

Ludmila N Bakhireva

http://www.w3.org/2001/XMLSchema#string

Ricki Bettencourt

http://www.w3.org/2001/XMLSchema#string

P2860

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin

Osteoclast differentiation and activation

The mechanisms of estrogen regulation of bone resorption.

RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function.

Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link?

Vascular calcification and osteoporosis--from clinical observation towards molecular understanding.

The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study.

Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice.

Differences in association of bone mineral density with coronary artery calcification in men and women: the Rancho Bernardo Study.

P304

2009-2012

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2007-2624

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth Barrett-Connor

P577

2008-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5533564

http://www.w3.org/2001/XMLSchema#string

P698

18319315

http://www.w3.org/2001/XMLSchema#string

P932

2386279

http://www.w3.org/2001/XMLSchema#string

Does osteoprotegerin or receptor activator of nuclear factor-kappaB ligand mediate the association between bone and coronary artery calcification?

about

P2860

P2860

Does osteoprotegerin or receptor activator of nuclear factor-kappaB ligand mediate the association between bone and coronary artery calcification?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932